Board meeting on Aug 5 to consider Q1 FY27 results

Board & Shareholder Meetings View source PDF

AUROPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Aurobindo Pharma's Board will meet on August 5, 2026 to consider and approve standalone and consolidated unaudited financial results for Q1 ended June 30, 2026. The trading window for the stock will remain closed until August 7 and reopen on August 8, 2026.

Likely market impact

Investors await Q1 FY27 earnings on Aug 5. Trading window closed until Aug 8 limits insider trades.